Squamous Cell Carcinoma of the Anal Canal (SCAC) Treatments
Find Squamous Cell Carcinoma of the Anal Canal (SCAC) Treatments
Medications for Squamous Cell Carcinoma of the Anal Canal (SCAC)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Squamous Cell Carcinoma of the Anal Canal (SCAC).
Found 1 Approved Drug for Squamous Cell Carcinoma of the Anal Canal (SCAC)
ZYNYZ
Generic Name
Retifanlimab-Dlwr
ZYNYZ
Generic Name
Retifanlimab-Dlwr
Form: Injection
Method of administration: Intravenous
FDA approval date: March 22, 2023
Classification: Programmed Death Receptor-1 Blocking Antibody
ZYNYZ is a programmed death receptor-1 (PD-1)–blocking antibody indicated: Squamous Cell Carcinoma of the Anal Canal (SCAC) in combination with carboplatin and paclitaxel for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC).
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances